Current research status of spleen stiffness measurement in predicting portal hypertension and its complications in patients with liver cirrhosis
10.3969/j.issn.1001-5256.2023.05.029
- VernacularTitle:脾脏硬度预测肝硬化患者门静脉高压及其并发症的研究现状
- Author:
Jiqing LIU
1
,
2
;
Fankun MENG
1
;
Huiguo DING
1
;
Jianjun LI
1
;
Qun HUANG
2
;
Hongmei ZU
2
;
Jing ZHANG
1
Author Information
1. Third Department of Liver Research Center, Beijing YouAn Hospital, Capital Medical University, Beijing 100069, China
2. Department of Hepatology, The Fourth People's Hospital of Qinghai Province, Xining 810000, China
- Publication Type:Review
- Keywords:
Liver Cirrhosis;
Hypertension, Portal;
Esophageal and Gastric Varices;
Spleen Stiffness
- From:
Journal of Clinical Hepatology
2023;39(5):1184-1190
- CountryChina
- Language:Chinese
-
Abstract:
Liver stiffness measurement (LSM) has been widely used in predicting portal hypertension in clinical practice, and in recent years, spleen stiffness measurement (SSM) has also become a diagnostic tool. Studies have shown that SSM can predict portal hypertension and its complications such as esophagogastric variceal bleeding in patients with chronic liver diseases and assist in the risk stratification management of portal hypertension and esophagogastric variceal bleeding. It can accurately predict clinically significant portal hypertension, high-risk esophageal and gastric varices, decompensation rate, and mortality rate in patients with chronic liver diseases. At present, SSM data in most studies are obtained by detection using the liver equipment FibroScan Ⓡ (SSM@50 Hz). FibroScan Ⓡ 630 is a new scanner dedicated for SSM with a special mode for SSM (SSM@100 Hz). This article elaborates on the significance of SSM in predicting portal hypertension and briefly introduces the advantages and disadvantages of the new equipment for SSM.
